TUESDAY INVESTOR DEADLINE Robbins Geller Rudman Dowd LLP Announces that Tandem Diabetes Care Inc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit TNDM

SAN DIEGO, Nov. 05, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, all dates inclusive (the “Class Period”), have until November 7, 2023 to seek appointment as…Read More